Publications
1 June 2023

Generation and characterization of induced pluripotent stem cell lines from two patients with recessive dystrophic epidermolysis Bullosa

Stem Cell Res. 2023 Jun;69:103104. doi: 10.1016/j.scr.2023.103104. Epub 2023 Apr 24. PMID: 37148821. Generation and characterization of induced pluripotent stem cell lines from two patients with […]
1 June 2023

Success of dupilumab in itchy recessive dystrophic epidermolysis bullosa of non-pruriginosa subtype

J Dermatol. 2023 Jun;50(6):837-842. doi: 10.1111/1346-8138.16729. Epub 2023 Jan 24. PMID: 36694424. Success of dupilumab in itchy recessive dystrophic epidermolysis bullosa of non-pruriginosa subtype Authors: Xue-Ge […]
5 June 2023

Low temperature and mTOR inhibition favor stemcell maintenance in human keratinocyte cultures

EMBO Rep. 2023 Jun 5;24(6):e55439. doi: 10.15252/embr.202255439. Epub 2023 May 4. PMID: 37139607; PMCID: PMC10240198. Low temperature and mTOR inhibition favor stem cell maintenance in human […]
8 June 2023

Unproven cell interventions in Poland and the exploitation of European Union law on advanced therapy medicinal products

Keywords: ATMP-HE; advanced therapy medicinal products; hospital exemption; stem cell therapies; stem cells; unproven cell therapies.
20 June 2023

Gene editing with ‘pencil’ rather than ‘scissors’ in human pluripotent stem cells

Keywords: Human pluripotent stem cells, Disease modeling, Ex vivo therapy, Isogenic pair, Base editors, Prime editor, Base substitution, Cas9
26 June 2023

Gene therapy advances shine the spotlight on epidermolysis bullosa, bringing hope to patients.

Keywords: recent different therapeutic gene therapy strategies
26 June 2023

Characterization of wound microbes in epidermolysis bullosa: A focus on Pseudomonas aeruginosa.

Keywords: epidermolysis bullosa; infection-bacterial; therapy-topical.
28 June 2023

Applications and sensory utilizations of magnetic levitation in 3D cell culture for tissue Engineering

Keywords: 3D cell culture; Magnetic levitation; Magnetic nanoparticle; Regenerative medicine; Scaffold-based and scaffold-free tissue engineering.
4 July 2023

ABSTRACT: Compassionate use of topical beremagene geperpavec (B-VEC) for the treatment of recurrent cicatrizing conjunctivitis in a patient with dystrophic epidermolysis bullosa

Keywords: B-VEC, Krystal, Opthalmology, Gene therapy